Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain

Abstract

Astrocytes, key regulators of brain homeostasis, interact with neighboring glial cells, neurons and the vasculature through complex processes involving different signaling pathways. It is not entirely clear how these interactions change in the ageing brain and which factors influence astrocyte ageing. Here, we investigate the role of endocannabinoid signaling, because it is an important modulator of neuron and astrocyte functions, as well as brain ageing. We demonstrate that mice with a specific deletion of CB1 receptors on GABAergic neurons (GABA-Cnr1-/- mice), which show a phenotype of accelerated brain ageing, affects age-related changes in the morphology of astrocytes in the hippocampus. Thus, GABA-Cnr1-/- mice showed a much more pronounced age-related and layer-specific increase in GFAP-positive areas in the hippocampus compared to wild-type animals. The number of astrocytes, in contrast, was similar between the two genotypes. Astrocytes in the hippocampus of old GABA-Cnr1-/- mice also showed a different morphology with enhanced GFAP-positive process branching and a less polarized intrahippocampal distribution. Furthermore, astrocytic TNFα levels were higher in GABA-Cnr1-/- mice, indicating that these morphological changes were accompanied by a more pro-inflammatory function. These findings demonstrate that the disruption of endocannabinoid signaling on GABAergic neurons is accompanied by functional changes in astrocyte activity, which are relevant to brain ageing.

Traumatic Brain Injury-related voiding dysfunction in mice is caused by damage to rostral pathways, altering inputs to the reflex pathways

“…Test session takes advantage of the innate tendency of mice to explore novel unexplored areas (e.g., the previously blocked arm). The time spent in novel unexplored areas of each animal was measured [79][80][81] . Mice first tested 2-months after the last injury, and then were retested 6-months later in the same maze but in a different environment.…”

A Guide to Targeting the Endocannabinoid System in Drug Design

“…Endocannabinoid signaling may also be beneficial because of its impact on attenuating neurotoxicity and neuroinflammation. It has been shown that deletion of CB1 accelerates brain aging through tumor necrosis factor α (TNF-α) [166], while CB1 agonism decreases neuroinflammation [167]. There have also been studies on FAAH inhibition impact on decreasing neuroinflammation [168] and exitoxicity in rodent models [169].…”

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders

“…Glial reactivity is a prominent characteristic among the cellular changes that appear in aged nervous tissue, an effect that is enhanced by absence of CB 1 receptors. Aged astrocytes and microgllia from CB 1 -knockout mice become more susceptible to activation and production of pro-inflammatory cytokines, even in the absence of antigenic stimulation [ 82 , 83 ]. Although astrocytes do not express eCB receptors at high levels under normal conditions, they are known to respond to eCBs via activation of CB 1 receptors, as well as producing both AEA and 2-AG [ 83 ].…”